Yang et al. showed that metformin ameliorates high glucose-induced cardiac damage through the AKT-GSK3β pathway in high glucose-exposed cardiomyocytes and animal models of diabetes [84]. This evidence concerns the gene AKT1 and diabetes mellitus.